Published ahead of print on May 11, 2007, doi:10.1164/rccm.200608-1114OC
American Journal of Respiratory and Critical Care Medicine Vol 176. pp. 253-260, (2007)
© 2007 American Thoracic Society
doi: 10.1164/rccm.200608-1114OC
Effect of Lung Volume Reduction Surgery on Resting Pulmonary Hemodynamics in Severe Emphysema
Gerard J. Criner1,
Steven M. Scharf2,
Jeremy A. Falk1,
John P. Gaughan1,
Alice L. Sternberg3,
Namrata B. Patel1,
Henry E. Fessler3,
Omar A. Minai4,
Alfred P. Fishman5 and
for the National Emphysema Treatment Trial Research Group*
1 Temple University, Philadelphia, Pennsylvania; 2 University of Maryland, Baltimore, Maryland; 3 Johns Hopkins University, Baltimore, Maryland; 4 Cleveland Clinic Foundation, Cleveland, Ohio; and 5 University of Pennsylvania, Philadelphia, Pennsylvania
Correspondence and requests for reprints should be addressed to Gerard J. Criner, M.D., Pulmonary and Critical Care Medicine, Temple University School of Medicine, 3401 North Broad Street, Philadelphia, PA 19140. E-mail: crinerg{at}tuhs.temple.edu
Rationale: To determine the effect of medical treatment versus lung volume reduction surgery (LVRS) on pulmonary hemodynamics.
Methods: Three clinical centers of the National Emphysema Treatment Trial (NETT) screened patients for additional inclusion into a cardiovascular (CV) substudy. Demographics were determined, and lung function testing, six-minute-walk distance, and maximum cardiopulmonary exercise testing were done at baseline and 6 months after medical therapy or LVRS. CV substudy patients underwent right heart catheterization at rest prerandomization (baseline) and 6 months after treatment.
Measurements and Main Results: A total of 110 of the 163 patients evaluated for the CV substudy were randomized in NETT (53 were ineligible), 54 to medical treatment and 56 to LVRS. Fifty-five of these patients had both baseline and repeat right heart catheterization 6 months postrandomization. Baseline demographics and lung function data revealed CV substudy patients to be similar to the remaining 1,163 randomized NETT patients in terms of age, sex, FEV1, residual volume, diffusion capacity of carbon monoxide, PaO2, PaCO2, and six-minute-walk distance. CV substudy patients had moderate pulmonary hypertension at rest ( , 24.8 ± 4.9 mm Hg); baseline hemodynamic measurements were similar across groups. Changes from baseline pressures to 6 months post-treatment were similar across treatment groups, except for a smaller change in pulmonary capillary wedge pressure at end-expiration post-LVRS compared with medical treatment (–1.8 vs. 3.5 mm Hg, p = 0.04).
Conclusions: In comparison to medical therapy, LVRS was not associated with an increase in pulmonary artery pressures.
Key Words: emphysema LVRS lung volume reduction
| AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
The effect of lung volume reduction surgery on pulmonary hemodynamics is controversial and has only been reported from small, uncontrolled, single-center trials.
What This Study Adds to the Field
In comparison to medical therapy, lung volume reduction surgery was not associated with an increase in pulmonary artery pressures.
|
This article has been cited by other articles:

|
 |

|
 |
 
P. J. Castaldi, C. P. Hersh, J. J. Reilly, and E. K. Silverman
Genetic Associations With Hypoxemia and Pulmonary Arterial Pressure in COPD
Chest,
March 1, 2009;
135(3):
737 - 744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chaouat, R. Naeije, and E. Weitzenblum
Pulmonary hypertension in COPD
Eur. Respir. J.,
November 1, 2008;
32(5):
1371 - 1385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. O'Donnell and K. A. Webb
The major limitation to exercise performance in COPD is dynamic hyperinflation
J Appl Physiol,
August 1, 2008;
105(2):
753 - 755.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Clini and N. Ambrosino
Nonpharmacological treatment and relief of symptoms in COPD
Eur. Respir. J.,
July 1, 2008;
32(1):
218 - 228.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Falk, S. Kadiev, G. J. Criner, S. M. Scharf, O. A. Minai, and P. Diaz
Cardiac Disease in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2008;
5(4):
543 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Lederer, E. K. T. Benn, R. G. Barr, J. S. Wilt, G. Reilly, J. R. Sonett, S. M. Arcasoy, and S. M. Kawut
Racial Differences in Waiting List Outcomes in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
February 15, 2008;
177(4):
450 - 454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Falk, U. J. Martin, S. Scharf, and G. J. Criner
Lung Elastic Recoil Does Not Correlate With Pulmonary Hemodynamics in Severe Emphysema
Chest,
November 1, 2007;
132(5):
1476 - 1484.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 American Thoracic Society
|
|
|